Isoray Reschedules Fourth Quarter and Fiscal Year End 2021 Financial Results Conference Call to September 22, 2021 Due to Conference Provider Technical Issues
Isoray has announced a rescheduled conference call on September 22, 2021, at 10:00 a.m. ET to discuss financial results for the fourth quarter and fiscal year ended June 30, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Isoray has announced a rescheduled conference call on September 22, 2021, at 10:00 a.m. ET to discuss financial results for the fourth quarter and fiscal year ended June 30, 2021. Initially planned earlier, the call was postponed due to technical issues with the conference bridge provider. The financial results were already released on September 21, 2021, after market close. Investors can access the call by dialing 888-506-0062, or 973-528-0011 for international callers, with a simultaneous webcast available for broader accessibility.
Details
News Market Reaction – ISR
The recorded move for ISR in the trading session of this news was -3.68%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Call Rescheduled for Wednesday, September 22 at 10:00 a.m. ET/7:00 a.m. PT
RICHLAND, Wash., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, will host a rescheduled conference call to discuss its financial results for the fourth quarter and fiscal year ended June 30, 2021 on Wednesday, September 22, 2021, at 10:00 a.m. Eastern Time/7:00 a.m. Pacific.
The rescheduled conference call was necessitated by the conference bridge provider’s technical failure. The Company has already issued a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2021. The press release was issued after the close of the U.S. stock markets on September 21, 2021.
To listen to the conference call, please dial 888-506-0062. For callers outside the U.S., please dial 973-528-0011.
The conference call will be simultaneously webcast and can be accessed at https://www.webcaster4.com/Webcast/Page/2199/42976. The webcast will be available until December 22, 2021 following the conference call.
About Isoray
Isoray, Inc. is a medical technology company pioneering advanced treatment applications and devices to deliver targeted internal radiation treatments for cancers throughout the body. Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.